Since the expression of both E2F1 and its target genes is downregulated upon treatment with diclofenac and indomethacin, we wanted to determine whether E2F1 was involved in the growth inhibitory effects of NSAIDs in ovarian cancer cells. Here, E2F1 is linked to ovarian cancer.